Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13441)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2014 (publication date) through Jul 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Currie G, McKay G, Delles C. Biomarkers in diabetic nephropathy: Present and future. World J Diabetes 2014; 5(6): 763-776 [PMID: 25512779 DOI: 10.4239/wjd.v5.i6.763] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i6/763.htm |
| Number | Citing Articles |
| 1 |
Jamal Ahmad. Management of diabetic nephropathy: Recent progress and future perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2015; 9(4): 343 doi: 10.1016/j.dsx.2015.02.008
|
| 2 |
C. Hizel, J. Tremblay, G. Bartlett, P. Hamet. Progress and Challenges in Precision Medicine. 2017; : 1 doi: 10.1016/B978-0-12-809411-2.00001-5
|
| 3 |
Gemma Currie, Christian Delles. Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients. Current Hypertension Reports 2016; 18(7) doi: 10.1007/s11906-016-0661-6
|
| 4 |
E. B. Popykhova, A. N. Ivanov, T. V. Stepanova, D. D. Lagutina, A. A. Savkina. Diabetic Nephropathy – possibilities of early laboratory diagnostics and course prediction (review of literature). Russian Clinical Laboratory Diagnostics 2021; 66(10): 593 doi: 10.51620/0869-2084-2021-66-10-593-602
|
| 5 |
Lilia Abbad, Niki Prakoura, Arthur Michon, Rym Chalghoumi, Simone Reichelt-Wurm, Miriam C. Banas, Christos Chatziantoniou. Role of Periostin and Nuclear Factor-κB Interplay in the Development of Diabetic Nephropathy. Cells 2022; 11(14): 2212 doi: 10.3390/cells11142212
|
| 6 |
Arlinda R. Driza, Georgia V. Kapoula, Pantelis G. Bagos. Urinary N-Acetyl-β-d-glucosaminidase (uNAG) as an Indicative Biomarker of Early Diabetic Nephropathy in Patients with Diabetes Mellitus (T1DM, T2DM): A Systematic Review and Meta-Analysis. Diabetology 2021; 2(4): 272 doi: 10.3390/diabetology2040025
|
| 7 |
Elizabeth Sorvor, William K. B. A. Owiredu, Perditer Okyere, Max Efui Annani-Akollor, Sampson Donkor, Richard Bannor, Felix B.K. Sorvor, Richard K.D. Ephraim. Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis. Frontiers in Clinical Diabetes and Healthcare 2022; 3 doi: 10.3389/fcdhc.2022.881202
|
| 8 |
Alina Golea-Secara, Cristian Munteanu, Mirela Sarbu, Octavian M Cretu, Silvia Velciov, Adrian Vlad, Flaviu Bob, Florica Gadalean, Cristina Gluhovschi, Oana Milas, Anca Simulescu, Maria Mogos-Stefan, Mihaela Patruica, Ligia Petrica, Alina D Zamfir. Urinary Proteins Detected Using Modern Proteomics Intervene in Early Type 2 Diabetic Kidney Disease – A Pilot Study. Biomarkers in Medicine 2020; 14(16): 1521 doi: 10.2217/bmm-2020-0308
|
| 9 |
Lin Mu, Nan Chen, Yakun Chen, Zhifen Yang, Huandi Zhou, Shan Song, Yonghong Shi, Vikas Kumar Roy. Blocking REDD1/TXNIP Complex Ameliorates HG-Induced Renal Tubular Epithelial Cell Apoptosis and EMT through Repressing Oxidative Stress. International Journal of Endocrinology 2022; 2022: 1 doi: 10.1155/2022/6073911
|
| 10 |
Lay-Harn Gam. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2023; : 791 doi: 10.1007/978-3-031-08014-2_42
|
| 11 |
Diğdem Bezen, Eren Vurgun, Hasan Dursun. Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes. Pediatric Nephrology 2023; 38(11): 3693 doi: 10.1007/s00467-023-06012-x
|
| 12 |
Carole G. Campion, Oraly Sanchez-Ferras, Sri N. Batchu. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Canadian Journal of Kidney Health and Disease 2017; 4: 205435811770537 doi: 10.1177/2054358117705371
|
| 13 |
Luigi Rossi, Maria Celeste Nicoletti, Monica Carmosino, Lisa Mastrofrancesco, Antonella Di Franco, Francesca Indrio, Rossella Lella, Luigi Laviola, Francesco Giorgino, Maria Svelto, Loreto Gesualdo, Giuseppe Procino. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/4360357
|
| 14 |
Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 1 doi: 10.1007/978-3-030-81303-1_59-1
|
| 15 |
Laale F. Alawi, Sanjeev Dhakal, Sana E. Emberesh, Harshal Sawant, Anhar Hosawi, Unmesha Thanekar, Nadja Grobe, Khalid M. Elased. Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension. Frontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.602985
|
| 16 |
Huifang Dai, Lielie Zhu, Bilin Pan, Hai Li, ZhiJuan Dai, Xiaoyou Su. The relationship between serum γ-glutamyltransferase (GGT) and diabetic nephropathy in patients with type 2 diabetes mellitus: a cross-sectional study. Clinical and Experimental Medicine 2023; 23(7): 3619 doi: 10.1007/s10238-023-00991-9
|
| 17 |
Suman Sapkota, Saroj Khatiwada, Shrijana Shrestha, Nirmal Baral, Robin Maskey, Shankar Majhi, Lal Chandra, Madhab Lamsal, Martin Sedlacek. Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus. International Journal of Nephrology 2021; 2021: 1 doi: 10.1155/2021/8884126
|
| 18 |
Nicholas J Radcliffe, Jas‐mine Seah, Michele Clarke, Richard J MacIsaac, George Jerums, Elif I Ekinci. Clinical predictive factors in diabetic kidney disease progression. Journal of Diabetes Investigation 2017; 8(1): 6 doi: 10.1111/jdi.12533
|
| 19 |
Elahe Soltani-Fard, Sina Taghvimi, Farzaneh Karimi, Farzaneh Vahedi, Seyyed Hossein Khatami, Hamid Behrooj, Mojdeh Deylami Hayati, Ahmad Movahedpour, Hassan Ghasemi. Urinary biomarkers in diabetic nephropathy. Clinica Chimica Acta 2024; 561: 119762 doi: 10.1016/j.cca.2024.119762
|
| 20 |
Liqun Ma, Rongguo Fu, Zhaoyang Duan, Jiamei Lu, Jie Gao, Lifang Tian, Zhian Lv, Zhao Chen, Jin Han, Lining Jia, Li Wang. Sirt1 is essential for resveratrol enhancement of hypoxia-induced autophagy in the type 2 diabetic nephropathy rat. Pathology - Research and Practice 2016; 212(4): 310 doi: 10.1016/j.prp.2016.02.001
|
| 21 |
Mona Hussein El-Samahy, AA Adly, Yasmine Ibrahim Elhenawy, EA Ismail, Shaimaa Abdelmalik Pessar, Mohamed El-Sayed Mowafy, Mohammed Salah Saad, Hossam Hassan Mohammed. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. Journal of Diabetes and its Complications 2018; 32(2): 185 doi: 10.1016/j.jdiacomp.2017.10.014
|
| 22 |
Xin-Ping Zhao, Shiao-Ying Chang, Min-Chun Liao, Chao-Sheng Lo, Isabelle Chenier, Hongyu Luo, Jean-Louis Chiasson, Julie R. Ingelfinger, John S. D. Chan, Shao-Ling Zhang. Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24220-6
|
| 23 |
Mohamed Hassan, Mohamed M. Aboelnaga, Mohamed Al-arman, Elsayed Z. Hatata. Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2021; 15(4): 102152 doi: 10.1016/j.dsx.2021.05.025
|
| 24 |
Association of the ACE (rs1800764) Polymorphism with Risk of Diabetic Kidney Disease in Saudi Arabian Population: A Pilot Study using the PCR-RFLP Method. Cytology and Genetics 2019; 53(6): 502 doi: 10.3103/S0095452719060069
|
| 25 |
Astha Jaiswal, Bhupesh Chandra Semwal, Sonia Singh. Effect of Captopril and BQ123 Endothelin-1 Antagonist on Experimentally
Induced Hyperlipidemic Nephropathy in Rats. Recent Patents on Biotechnology 2023; 17(2): 151 doi: 10.2174/1872208316666220629150347
|
| 26 |
Ibrahim Abdulsada, Zain Alabdeen Obaid, Farah Almerza, Mays Alwaeli, Anmar Al-Elayawi, Taha Al-Dayyeni, Harir Al-Tuhafy. Determination of Diabetes-associated Cardiovascular Autonomic Neuropathy Risk Factors among Insulin and Non-insulin Dependent Diabetics. The Journal of Medical Research 2023; 9(6): 141 doi: 10.31254/jmr.2023.9603
|
| 27 |
Qian Li, Bao Li, Chang-Liang Lu, Jing-Ye Wang, Min Gao, Wei Gao. LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma. Cancer Gene Therapy 2021; 28(9): 1046 doi: 10.1038/s41417-020-00267-4
|
| 28 |
Rajesh Jha, Sara Lopez-Trevino, Haritha R. Kankanamalage, Jay C. Jha. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions. Biomedicines 2024; 12(5): 1098 doi: 10.3390/biomedicines12051098
|
| 29 |
Sandra Božičević, Marijana Vučić Lovrenčić, Lea Smirčić Duvnjak. Diagnostic challenges of diabetic kidney disease. Biochemia medica 2023; 33(3): 227 doi: 10.11613/BM.2023.030501
|
| 30 |
Haoxue Gao, Xiaoyi Yu, Runbin Sun, Na Yang, Jun He, Mingxue Tao, Huilin Gu, Caixia Yan, Jiye Aa, Guangji Wang. Quantitative GC–MS assay of citric acid from humans and db/db mice blood serum to assist the diagnosis of diabetic nephropathy. Journal of Chromatography B 2018; : 28 doi: 10.1016/j.jchromb.2017.12.021
|
| 31 |
Naseer Ullah Khan, Jing Lin, Xukun Liu, Haiying Li, Wei Lu, Zhuning Zhong, Huajie Zhang, Muhammad Waqas, Liming Shen. Insights into predicting diabetic nephropathy using urinary biomarkers. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2020; 1868(10): 140475 doi: 10.1016/j.bbapap.2020.140475
|
| 32 |
Sara Nunes, André Alves, Inês Preguiça, Adelaide Barbosa, Pedro Vieira, Fernando Mendes, Diana Martins, Sofia D. Viana, Flávio Reis. Crescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric Diet. Nutrients 2020; 12(4): 881 doi: 10.3390/nu12040881
|
| 33 |
Naveenah Udaya Surian, Arsen Batagov, Andrew Wu, Wen Bin Lai, Yan Sun, Yong Mong Bee, Rinkoo Dalan. A digital twin model incorporating generalized metabolic fluxes to identify and predict chronic kidney disease in type 2 diabetes mellitus. npj Digital Medicine 2024; 7(1) doi: 10.1038/s41746-024-01108-6
|
| 34 |
|
| 35 |
Federica Storti, Jennifer Pulley, Pascal Kuner, Markus Abt, Ulrich F. O. Luhmann. Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy. Translational Vision Science & Technology 2021; 10(12): 8 doi: 10.1167/tvst.10.12.8
|
| 36 |
Zhi Su, Deborah Widomski, Ji Ma, Marian Namovic, Arthur Nikkel, Laura Leys, Lauren Olson, Katherine Salte, Diana Donnelly-Roberts, Timothy Esbenshade, Steve McGaraughty. Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy. American Journal of Nephrology 2016; 44(5): 339 doi: 10.1159/000449324
|
| 37 |
Gemma Currie, Sheon Mary, Christian Delles. Is there a role for proteomics in diabetic renal disease?. Nephrology Dialysis Transplantation 2020; 35(7): 1133 doi: 10.1093/ndt/gfz017
|
| 38 |
Kamal Taha, Ramana Davuluri, Paul Yoo, Jesse Spencer, Lars Kaderali. Personizing the prediction of future susceptibility to a specific disease. PLOS ONE 2021; 16(1): e0243127 doi: 10.1371/journal.pone.0243127
|
| 39 |
Shilin Li, Antoine Brault, Mayra Sanchez Villavicencio, Pierre S. Haddad. Rhododendron groenlandicum(Labrador tea), an antidiabetic plant from the traditional pharmacopoeia of the Canadian Eastern James Bay Cree, improves renal integrity in the diet-induced obese mouse model. Pharmaceutical Biology 2016; 54(10): 1998 doi: 10.3109/13880209.2015.1137953
|
| 40 |
Tomás P. Griffin, William Patrick Martin, Nahidul Islam, Timothy O’Brien, Matthew D. Griffin. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease. Current Diabetes Reports 2016; 16(5) doi: 10.1007/s11892-016-0734-6
|
| 41 |
Qing Zhang, Yongqiang Ji, Wei Lv, Tianwei He, Jianping Wang. Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy. Renal Failure 2016; 38(1): 124 doi: 10.3109/0886022X.2015.1105024
|
| 42 |
Carmen Muntean, Iuliana Magdalena Starcea, Claudia Banescu. Diabetic kidney disease in pediatric patients: A current review. World Journal of Diabetes 2022; 13(8): 587-599 doi: 10.4239/wjd.v13.i8.587
|
| 43 |
P. J. Padmini, V. Ashok. Urine neutrophil gelatinase-associated lipocalin as an early biochemical marker of microalbuminuria in predicting early kidney damage in patients with type 2 diabetes mellitus. The Ukrainian Biochemical Journal 2021; 93(6): 55 doi: 10.15407/ubj93.06.055
|
| 44 |
Sonia Mota-Zamorano, Nicolás R. Robles, Luz M. González, José M. Valdivielso, Juan Lopez-Gomez, Bárbara Cancho, Guadalupe García-Pino, Guillermo Gervasini. Genetics Variants in the Epoxygenase Pathway of Arachidonic Metabolism Are Associated with Eicosanoids Levels and the Risk of Diabetic Nephropathy. Journal of Clinical Medicine 2021; 10(17): 3980 doi: 10.3390/jcm10173980
|
| 45 |
BenibobaJenewari Eleki, PedroC Emem-Chioma. Prevalence and Spectrum of Albuminuria among Type 2 Diabetic Patients in a Tertiary Health-care Facility in Southern Nigeria. Nigerian Journal of Medicine 2023; 32(1): 39 doi: 10.4103/NJM.NJM_119_22
|
| 46 |
Dongmei Sun, Yifei Hu, Yongjun Ma, Huabin Wang. Predictive role of serum C-peptide in new-onset renal dysfunction in type 2 diabetes: a longitudinal observational study. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1227260
|
| 47 |
Khalid Al-Rubeaan, Khalid Siddiqui, Mohammed A. Al-Ghonaim, Amira M. Youssef, Ahmed H. Al-Sharqawi, Dhekra AlNaqeb. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02421-9
|
| 48 |
Dhamodharan Umapathy, Sireesh Dornadula, Ezhilarasi Krishnamoorthy, Vairamani Mariappanadar, Vijay Viswanathan, Kunka Mohanram Ramkumar. YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines. Immunobiology 2018; 223(11): 718 doi: 10.1016/j.imbio.2018.07.020
|
| 49 |
Samuel N. Uwaezuoke, Ugo N. Chikani, Ngozi R. Mbanefo. Advances in Nephropathy. 2018; doi: 10.5772/intechopen.79331
|
| 50 |
Giuseppe Penno, Eleonora Russo, Monia Garofolo, Giuseppe Daniele, Daniela Lucchesi, Laura Giusti, Veronica Sancho Bornez, Cristina Bianchi, Angela Dardano, Roberto Miccoli, Stefano Del Prato. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. Diabetologia 2017; 60(6): 1102 doi: 10.1007/s00125-017-4251-1
|
| 51 |
Mayara Karla dos Santos Nunes, Alexandre Sérgio Silva, Isabella Wanderley de Queiroga Evangelista, João Modesto Filho, Cecília Neta Alves Pegado Gomes, Rayner Anderson Ferreira do Nascimento, Rafaella Cristhine Pordeus Luna, Maria José de Carvalho Costa, Naila Francis Paulo de Oliveira, Darlene Camati Persuhn. Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators. Diabetology & Metabolic Syndrome 2017; 9(1) doi: 10.1186/s13098-017-0284-3
|
| 52 |
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis, Dimitri P Mikhailidis. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opinion on Pharmacotherapy 2015; 16(10): 1449 doi: 10.1517/14656566.2015.1053464
|
| 53 |
Mosa Osama, Rizk Mahmoud, Asmaa Said. Microalbuminuria besides to urinary enzymatic protein levels increase in Diabetic kidney disease with type II diabetics. Sanamed 2018; 13(2): 145 doi: 10.24125/sanamed.v13i2.254
|
| 54 |
Jing Ning, Zhicong Xiang, Chongxiang Xiong, Qin Zhou, Xin Wang, Hequn Zou. <p>Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 2037 doi: 10.2147/DMSO.S250347
|
| 55 |
Khalid Siddiqui, Salini Scaria Joy, Shaik Sarfaraz Nawaz, Dhekra Alnaqeb, Muhammad Mujammami, Khalid Al-Rubeaan. Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-01906-6
|
| 56 |
Umm E. Habiba, Nasar Khan, David Lawrence Greene, Sabiha Shamim, Amna Umer. The therapeutic effect of mesenchymal stem cells in diabetic kidney disease. Journal of Molecular Medicine 2024; 102(4): 537 doi: 10.1007/s00109-024-02432-w
|
| 57 |
Leena Mamilly, Lucy D. Mastrandrea, Claudia Mosquera Vasquez, Brett Klamer, Mahmoud Kallash, Ahmad Aldughiem. Evidence of Early Diabetic Nephropathy in Pediatric Type 1 Diabetes. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.669954
|
| 58 |
Xiaoting Duan, Cheng Chen, Xiaoli Liu, Taoxia Wang, Shuning Feng, Jianwei Li, Guiying Li. Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury. Genes & Genomics 2023; 45(11): 1389 doi: 10.1007/s13258-023-01400-x
|
| 59 |
Akiko Sakurai, Hiroyuki Ono, Arisa Ochi, Motokazu Matsuura, Sakiya Yoshimoto, Seiji Kishi, Taichi Murakami, Tatsuya Tominaga, Kojiro Nagai, Hideharu Abe, Toshio Doi, Utpal Sen. Involvement of Elf3 on Smad3 activation-dependent injuries in podocytes and excretion of urinary exosome in diabetic nephropathy. PLOS ONE 2019; 14(5): e0216788 doi: 10.1371/journal.pone.0216788
|
| 60 |
Zoi Kleinaki, Stella Kapnisi, Sofia-Andriani Theodorelou-Charitou, Ilias P. Nikas, Stavroula A. Paschou. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update. Hormones 2020; 19(4): 467 doi: 10.1007/s42000-020-00212-y
|
| 61 |
Lang Han, Xiaojiao Chen, Dianwei Wan, Min Xie, Shurui Ouyang. One anastomosis gastric bypass ameliorates diabetic nephropathy via regulating the GLP-1-mediated Sirt1/AMPK/PGC1α pathway. Clinical and Experimental Nephrology 2024; doi: 10.1007/s10157-024-02516-4
|
| 62 |
G. Currie, C. Delles. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy. Current Diabetes Reports 2016; 16(11) doi: 10.1007/s11892-016-0798-3
|
| 63 |
Cristina Gluhovschi, Gheorghe Gluhovschi, Ligia Petrica, Romulus Timar, Silvia Velciov, Ioana Ionita, Adriana Kaycsa, Bogdan Timar. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4626125
|
| 64 |
Sander De Bruyne, Jo Van Dorpe, Jonas Himpe, Wim Van Biesen, Sigurd Delanghe, Marijn M. Speeckaert, Joris R. Delanghe. Detection and Characterization of a Biochemical Signature Associated with Diabetic Nephropathy Using Near-infrared Spectroscopy on Tissue Sections. Journal of Clinical Medicine 2019; 8(7): 1022 doi: 10.3390/jcm8071022
|
| 65 |
Agnieszka Los-Stegienta, Anna Borkowska, Katarzyna Cypryk. Assessment of microvascular function using a novel technique Flow Mediated Skin Fluorescence (FMSF) in patients with diabetic kidney disease: A preliminary study. Microvascular Research 2022; 144: 104417 doi: 10.1016/j.mvr.2022.104417
|
| 66 |
Koen W. Streng, Hans L. Hillege, Jozine M. ter Maaten, Dirk J. van Veldhuisen, Kenneth Dickstein, Nilesh J. Samani, Leong L. Ng, Marco Metra, Gerasimos S. Filippatos, Piotr Ponikowski, Faiez Zannad, Stefan D. Anker, Peter van der Meer, Chim C. Lang, Adriaan A. Voors, Kevin Damman. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction. Journal of Cardiovascular Translational Research 2024; 17(1): 3 doi: 10.1007/s12265-023-10356-y
|
| 67 |
M. V. Shestakova. Diabetes mellitus and chronic kidney disease: Possibilities of prediction, early diagnosis, and nephroprotection in the 21st century. Terapevticheskii arkhiv 2016; 88(6): 84 doi: 10.17116/terarkh201688684-88
|
| 68 |
Zhengtao Qin, Carl K. Hoh, Emilia S. Olson, Amin Haghighat Jahromi, David J. Hall, Christopher V. Barback, Young-Hyun You, Motoko Yanagita, Kumar Sharma, David R. Vera. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept. Journal of Nuclear Medicine 2019; 60(9): 1325 doi: 10.2967/jnumed.118.223727
|
| 69 |
Elfiani Elfiani, Anggelia Puspasari, Zulkhair Ali. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2023; : 469 doi: 10.1007/978-3-031-08014-2_59
|
| 70 |
Hicham Benabdelkamel, Afshan Masood, Meshail Okla, Mohammed Y. Al-Naami, Assim A. Alfadda. A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients. International Journal of Molecular Sciences 2019; 20(19): 4905 doi: 10.3390/ijms20194905
|
| 71 |
Lay-Harn Gam. Biomarkers in Diabetes. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 1 doi: 10.1007/978-3-030-81303-1_42-1
|
| 72 |
Qijin Zhu, Xiangming Qi, Yonggui Wu, Kun Wang. Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. International Urology and Nephrology 2016; 48(11): 1873 doi: 10.1007/s11255-016-1345-5
|
| 73 |
Yanjuan Hou, Yonghong Shi, Baosheng Han, Xuqian Liu, Xi Qiao, Yue Qi, Lihua Wang. The antioxidant peptide SS31 prevents oxidative stress, downregulates CD36 and improves renal function in diabetic nephropathy. Nephrology Dialysis Transplantation 2018; 33(11): 1908 doi: 10.1093/ndt/gfy021
|
| 74 |
Benan Kasapoglu, Cansel Turkay, Kadir Serkan Yalcın, Salih Boga, Alper Bozkurt. Increased microalbuminuria prevalence among patients with nonalcoholic fatty liver disease. Renal Failure 2016; 38(1): 15 doi: 10.3109/0886022X.2015.1106845
|
| 75 |
O K Vikulova, Z T Zuraeva, O V Michaleva, L V Nikankina, M Sh Shamkhalova, M V Shestakova, I I Dedov. Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus. Terapevticheskii arkhiv 2018; 90(6): 59 doi: 10.26442/terarkh201890659-64
|
| 76 |
Deyuan Zhang, Shandong Ye, Tianrong Pan. The role of serum and urinary biomarkers in the diagnosis of early diabetic nephropathy in patients with type 2 diabetes. PeerJ 2019; 7: e7079 doi: 10.7717/peerj.7079
|
| 77 |
Zhila Semnani-Azad, Windy Z N Wang, David E C Cole, Luke W Johnston, Betty Y L Wong, Lei Fu, Ravi Retnakaran, Stewart B Harris, Anthony J Hanley. Urinary Vitamin D Binding Protein: A Marker of Kidney Tubular Dysfunction in Patients at Risk for Type 2 Diabetes. Journal of the Endocrine Society 2024; 8(3) doi: 10.1210/jendso/bvae014
|
| 78 |
Jun-Ya Kaimori, Yoshitaka Isaka, Masaki Hatanaka, Satoko Yamamoto, Naotsugu Ichimaru, Akihiko Fujikawa, Hiroshi Shibata, Akira Fujimori, Sosuke Miyoshi, Takashi Yokawa, Kagayaki Kuroda, Toshiki Moriyama, Hiromi Rakugi, Shiro Takahara. Visualization of kidney fibrosis in diabetic nephropathy by long diffusion tensor imaging MRI with spin-echo sequence. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06111-4
|
| 79 |
Thapelo Mbhele, Donald M. Tanyanyiwa, Refilwe J. Moepya, Sindeep Bhana, Maya M. Makatini. Relationship between amino acid ratios and decline in estimated glomerular filtration rate in diabetic and non-diabetic patients in South Africa. African Journal of Laboratory Medicine 2021; 10(1) doi: 10.4102/ajlm.v10i1.1398
|
| 80 |
Agnieszka Żyłka, Paulina Dumnicka, Beata Kuśnierz-Cabala, Agnieszka Gala-Błądzińska, Piotr Ceranowicz, Jakub Kucharz, Anna Ząbek-Adamska, Barbara Maziarz, Ryszard Drożdż, Marek Kuźniewski. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/7659243
|
| 81 |
Axel C Carlsson, Johan Sundström, Juan Jesus Carrero, Stefan Gustafsson, Markus Stenemo, Anders Larsson, Lars Lind, Johan Ärnlöv. Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria. European Journal of Preventive Cardiology 2017; 24(4): 340 doi: 10.1177/2047487316676134
|
| 82 |
Pavana A, Vasudha K C, Pramila Kalra. Urinary transferrin as early marker of renal damage in type II diabetes mellitus: A case–control study. International Journal of Clinical Biochemistry and Research 2021; 8(1): 33 doi: 10.18231/j.ijcbr.2021.008
|